カテゴリー： QYResearch, 世界, 医療/バイオ

世界の中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）市場インサイト及び予測（100ml、250ml、500ml、1000ml）

◆英語タイトル：Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX10406）◆商品コード：QY22JLX10406
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：109
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の世界市場のxxx％を占める「100ml」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）のグローバル主要企業には、Fresenius Kabi、B. Braun、Otsuka Pharmaceutical、CR Double-Crane、Haisco、Libang、Cisen Pharmaceutical、Kelun、AnHui BBCA Pharmaceutical、YaoPharma、Guangdong Jiabo Pharmaceutical、Jiangsu Hengrui Pharmaceuticals、WEGO、Jiangsu Yingke Biopharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）市場は、種類と用途によって区分されます。世界の中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
100ml、250ml、500ml、1000ml

【用途別セグメント】
病院、診療所、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）製品概要
- 種類別市場（100ml、250ml、500ml、1000ml）
- 用途別市場（病院、診療所、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）販売量予測2017-2028
- 世界の中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）売上予測2017-2028
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の地域別販売量
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）販売量
- 主要メーカー別中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）売上
- 主要メーカー別中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（100ml、250ml、500ml、1000ml）
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の種類別販売量
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の種類別売上
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の種類別価格
・用途別市場規模（病院、診療所、その他）
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の用途別販売量
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の用途別売上
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の用途別価格
・北米市場
- 北米の中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）市場規模（種類別、用途別）
- 主要国別の中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）市場規模（種類別、用途別）
- 主要国別の中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）市場規模（種類別、用途別）
- 主要国別の中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）市場規模（種類別、用途別）
- 主要国別の中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）市場規模（種類別、用途別）
- 主要国別の中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）市場規模（トルコ、サウジアラビア）
・企業情報
Fresenius Kabi、B. Braun、Otsuka Pharmaceutical、CR Double-Crane、Haisco、Libang、Cisen Pharmaceutical、Kelun、AnHui BBCA Pharmaceutical、YaoPharma、Guangdong Jiabo Pharmaceutical、Jiangsu Hengrui Pharmaceuticals、WEGO、Jiangsu Yingke Biopharmaceutical
・産業チェーン及び販売チャネル分析
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の産業チェーン分析
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の原材料
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の生産プロセス
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の販売及びマーケティング
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の産業動向
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）のマーケットドライバー
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の課題
- 中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）の阻害要因
・主な調査結果

Market Analysis and Insights: Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market
Due to the COVID-19 pandemic, the global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 100ml accounting for % of the Medium and Long Chain Fat Emulsion Injection (C8-24Ve) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Medium and Long Chain Fat Emulsion Injection (C8-24Ve) market size is valued at US$ million in 2021, while the US and Europe Medium and Long Chain Fat Emulsion Injection (C8-24Ve) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Medium and Long Chain Fat Emulsion Injection (C8-24Ve) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Medium and Long Chain Fat Emulsion Injection (C8-24Ve) include Fresenius Kabi, B. Braun, Otsuka Pharmaceutical, CR Double-Crane, Haisco, Libang, Cisen Pharmaceutical, Kelun and AnHui BBCA Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Scope and Segment
Medium and Long Chain Fat Emulsion Injection (C8-24Ve) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
100ml
250ml
500ml
1000ml
Segment by Application
Hospitals
Clinics
Others
By Company
Fresenius Kabi
B. Braun
Otsuka Pharmaceutical
CR Double-Crane
Haisco
Libang
Cisen Pharmaceutical
Kelun
AnHui BBCA Pharmaceutical
YaoPharma
Guangdong Jiabo Pharmaceutical
Jiangsu Hengrui Pharmaceuticals
WEGO
Jiangsu Yingke Biopharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Product Introduction
1.2 Market by Type
1.2.1 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 100ml
1.2.3 250ml
1.2.4 500ml
1.2.5 1000ml
1.3 Market by Application
1.3.1 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales Estimates and Forecasts 2017-2028
2.2 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue Estimates and Forecasts 2017-2028
2.3 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Region
2.4.1 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Region (2017-2022)
2.4.2 Global Sales Medium and Long Chain Fat Emulsion Injection (C8-24Ve) by Region (2023-2028)
2.5 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Region
2.5.1 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Region (2017-2022)
2.5.2 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Manufacturers
3.1.1 Global Top Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Manufacturers by Sales (2017-2022)
3.1.2 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Medium and Long Chain Fat Emulsion Injection (C8-24Ve) in 2021
3.2 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Manufacturers
3.2.1 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Manufacturers (2017-2022)
3.2.2 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue in 2021
3.3 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Type
4.1.1 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Historical Sales by Type (2017-2022)
4.1.2 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Forecasted Sales by Type (2023-2028)
4.1.3 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales Market Share by Type (2017-2028)
4.2 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Type
4.2.1 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Historical Revenue by Type (2017-2022)
4.2.2 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue Market Share by Type (2017-2028)
4.3 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Price by Type
4.3.1 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Price by Type (2017-2022)
4.3.2 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Application
5.1.1 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Historical Sales by Application (2017-2022)
5.1.2 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Forecasted Sales by Application (2023-2028)
5.1.3 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales Market Share by Application (2017-2028)
5.2 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Application
5.2.1 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Historical Revenue by Application (2017-2022)
5.2.2 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue Market Share by Application (2017-2028)
5.3 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Price by Application
5.3.1 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Price by Application (2017-2022)
5.3.2 Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size by Type
6.1.1 North America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Type (2017-2028)
6.1.2 North America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Type (2017-2028)
6.2 North America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size by Application
6.2.1 North America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Application (2017-2028)
6.2.2 North America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Application (2017-2028)
6.3 North America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size by Country
6.3.1 North America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Country (2017-2028)
6.3.2 North America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size by Type
7.1.1 Europe Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Type (2017-2028)
7.1.2 Europe Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Type (2017-2028)
7.2 Europe Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size by Application
7.2.1 Europe Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Application (2017-2028)
7.2.2 Europe Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Application (2017-2028)
7.3 Europe Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size by Country
7.3.1 Europe Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Country (2017-2028)
7.3.2 Europe Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size by Type
8.1.1 Asia Pacific Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Type (2017-2028)
8.1.2 Asia Pacific Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Type (2017-2028)
8.2 Asia Pacific Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size by Application
8.2.1 Asia Pacific Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Application (2017-2028)
8.2.2 Asia Pacific Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Application (2017-2028)
8.3 Asia Pacific Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size by Region
8.3.1 Asia Pacific Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Region (2017-2028)
8.3.2 Asia Pacific Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size by Type
9.1.1 Latin America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Type (2017-2028)
9.1.2 Latin America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Type (2017-2028)
9.2 Latin America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size by Application
9.2.1 Latin America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Application (2017-2028)
9.2.2 Latin America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Application (2017-2028)
9.3 Latin America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size by Country
9.3.1 Latin America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Country (2017-2028)
9.3.2 Latin America Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size by Type
10.1.1 Middle East and Africa Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Type (2017-2028)
10.2 Middle East and Africa Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size by Application
10.2.1 Middle East and Africa Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Application (2017-2028)
10.3 Middle East and Africa Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Size by Country
10.3.1 Middle East and Africa Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Fresenius Kabi
11.1.1 Fresenius Kabi Corporation Information
11.1.2 Fresenius Kabi Overview
11.1.3 Fresenius Kabi Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Fresenius Kabi Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Fresenius Kabi Recent Developments
11.2 B. Braun
11.2.1 B. Braun Corporation Information
11.2.2 B. Braun Overview
11.2.3 B. Braun Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 B. Braun Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 B. Braun Recent Developments
11.3 Otsuka Pharmaceutical
11.3.1 Otsuka Pharmaceutical Corporation Information
11.3.2 Otsuka Pharmaceutical Overview
11.3.3 Otsuka Pharmaceutical Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Otsuka Pharmaceutical Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Otsuka Pharmaceutical Recent Developments
11.4 CR Double-Crane
11.4.1 CR Double-Crane Corporation Information
11.4.2 CR Double-Crane Overview
11.4.3 CR Double-Crane Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 CR Double-Crane Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 CR Double-Crane Recent Developments
11.5 Haisco
11.5.1 Haisco Corporation Information
11.5.2 Haisco Overview
11.5.3 Haisco Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Haisco Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Haisco Recent Developments
11.6 Libang
11.6.1 Libang Corporation Information
11.6.2 Libang Overview
11.6.3 Libang Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Libang Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Libang Recent Developments
11.7 Cisen Pharmaceutical
11.7.1 Cisen Pharmaceutical Corporation Information
11.7.2 Cisen Pharmaceutical Overview
11.7.3 Cisen Pharmaceutical Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cisen Pharmaceutical Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cisen Pharmaceutical Recent Developments
11.8 Kelun
11.8.1 Kelun Corporation Information
11.8.2 Kelun Overview
11.8.3 Kelun Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Kelun Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Kelun Recent Developments
11.9 AnHui BBCA Pharmaceutical
11.9.1 AnHui BBCA Pharmaceutical Corporation Information
11.9.2 AnHui BBCA Pharmaceutical Overview
11.9.3 AnHui BBCA Pharmaceutical Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 AnHui BBCA Pharmaceutical Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AnHui BBCA Pharmaceutical Recent Developments
11.10 YaoPharma
11.10.1 YaoPharma Corporation Information
11.10.2 YaoPharma Overview
11.10.3 YaoPharma Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 YaoPharma Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 YaoPharma Recent Developments
11.11 Guangdong Jiabo Pharmaceutical
11.11.1 Guangdong Jiabo Pharmaceutical Corporation Information
11.11.2 Guangdong Jiabo Pharmaceutical Overview
11.11.3 Guangdong Jiabo Pharmaceutical Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Guangdong Jiabo Pharmaceutical Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Guangdong Jiabo Pharmaceutical Recent Developments
11.12 Jiangsu Hengrui Pharmaceuticals
11.12.1 Jiangsu Hengrui Pharmaceuticals Corporation Information
11.12.2 Jiangsu Hengrui Pharmaceuticals Overview
11.12.3 Jiangsu Hengrui Pharmaceuticals Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Jiangsu Hengrui Pharmaceuticals Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
11.13 WEGO
11.13.1 WEGO Corporation Information
11.13.2 WEGO Overview
11.13.3 WEGO Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 WEGO Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 WEGO Recent Developments
11.14 Jiangsu Yingke Biopharmaceutical
11.14.1 Jiangsu Yingke Biopharmaceutical Corporation Information
11.14.2 Jiangsu Yingke Biopharmaceutical Overview
11.14.3 Jiangsu Yingke Biopharmaceutical Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Jiangsu Yingke Biopharmaceutical Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Jiangsu Yingke Biopharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Industry Chain Analysis
12.2 Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Production Mode & Process
12.4 Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales and Marketing
12.4.1 Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Sales Channels
12.4.2 Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Distributors
12.5 Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Industry Trends
13.2 Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Drivers
13.3 Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Challenges
13.4 Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Restraints
14 Key Findings in The Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の中鎖＆長鎖脂肪エマルジョン注入（C8-24Ve）市場インサイト及び予測（100ml、250ml、500ml、1000ml）(Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の非経口栄養乳剤市場インサイト及び予測（100ml、250ml、500ml、1000ml）
  • 世界の経腸栄養懸濁液市場インサイト及び予測（250ml、500ml、1000ml）
  • 世界の中・長鎖脂肪乳化注入（ C8-24VE ）市場2022年：100ml、 250ml、 500ml、 1000ml
  • 世界の経腸栄養補給市場2022年：250ml、500ml、1000ml
  • 世界の非経口栄養エマルジョン市場2022年：100ml、250ml、500ml、1000ml